A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer.
10.1016/j.tranon.2020.100946 Chi et al. Transl Oncol
Chi F, Liu J, Brady SW, Cosgrove PA, Nath A, McQuerry JA, Majumdar S, Moos PJ, Chang JT, Kahn M, Bild AH
Study details